These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 18695898

  • 1. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y, Izumi M, Tachibana M, Kawamura T, Yoshioka K, Aoyagi T, Ohori M, Namiki K, Sakamoto N, Nakagami Y, Hatano T, Akimoto S, Nishimura T.
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [Abstract] [Full Text] [Related]

  • 2. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S, Tang XY, Umemura S, Itoh J, Takekoshi S, Shima M, Usui Y, Nagata Y, Uchida T, Osamura RY, Terachi T.
    Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
    [Abstract] [Full Text] [Related]

  • 3. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y, Katagiri T.
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [Abstract] [Full Text] [Related]

  • 4. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM, Gao G, Zhang F, Chen H, Wan YF, Li XQ.
    Zhonghua Yi Xue Za Zhi; 2006 Oct 24; 86(39):2749-55. PubMed ID: 17199993
    [Abstract] [Full Text] [Related]

  • 5. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.
    Gastroenterology; 2009 Jul 24; 137(1):165-75. PubMed ID: 19328798
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
    Weber KL, Pathak S, Multani AS, Price JE.
    J Urol; 2002 Aug 24; 168(2):774-9. PubMed ID: 12131367
    [Abstract] [Full Text] [Related]

  • 7. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T, Miyagawa I.
    Int J Urol; 2006 Mar 24; 13(3):257-64. PubMed ID: 16643620
    [Abstract] [Full Text] [Related]

  • 8. Differential protein profiling in renal-cell carcinoma.
    Shi T, Dong F, Liou LS, Duan ZH, Novick AC, DiDonato JA.
    Mol Carcinog; 2004 May 24; 40(1):47-61. PubMed ID: 15108329
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G.
    Clin Cancer Res; 2005 Jul 15; 11(14):5128-39. PubMed ID: 16033827
    [Abstract] [Full Text] [Related]

  • 11. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
    Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mochizuki S, Ikeda T, Mukai M, Okada Y.
    J Pathol; 2009 Aug 15; 218(4):530-9. PubMed ID: 19455604
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor gamma is frequently underexpressed in renal cell carcinoma.
    Yuan J, Takahashi A, Masumori N, Itoh N, Tsukamoto T.
    Int J Urol; 2006 Mar 15; 13(3):265-70. PubMed ID: 16643621
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M.
    J Pathol; 2008 Dec 15; 216(4):418-27. PubMed ID: 18925646
    [Abstract] [Full Text] [Related]

  • 15. BIGH3 is overexpressed in clear cell renal cell carcinoma.
    Yamanaka M, Kimura F, Kagata Y, Kondoh N, Asano T, Yamamoto M, Hayakawa M.
    Oncol Rep; 2008 Apr 15; 19(4):865-74. PubMed ID: 18357369
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knüchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG.
    Oncogene; 2007 Aug 16; 26(38):5680-91. PubMed ID: 17353908
    [Abstract] [Full Text] [Related]

  • 19. Metastases-related genes in the classification of liver and peritoneal metastasis in human gastric cancer.
    Fukui R, Nishimori H, Hata F, Yasoshima T, Ohno K, Nomura H, Yanai Y, Tanaka H, Kamiguchi K, Denno R, Sato N, Hirata K.
    J Surg Res; 2005 Nov 16; 129(1):94-100. PubMed ID: 16054651
    [Abstract] [Full Text] [Related]

  • 20. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma.
    Yusenko MV, Kovacs G.
    Histopathology; 2009 Dec 16; 55(6):687-95. PubMed ID: 20002769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.